Company GENFIT

Equities

GNFT

FR0004163111

Biotechnology & Medical Research

Real-time Euronext Paris 12:35:13 2024-03-28 pm EDT 5-day change 1st Jan Change
3.34 EUR +0.60% Intraday chart for GENFIT +2.93% -5.65%

Business Summary

GENFIT is a biopharmaceutical company in late-stage development focused on the discovery and development of innovative therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, in particular due to a lack of approved treatments. GENFIT is a leading innovator in the field of nuclear receptor-based drug discovery with a rich history and a solid scientific heritage spanning nearly two decades.

The company has offices in Lille, Paris and Cambridge, MA (USA) and employs approximately 200 people.

Number of employees: 154

Sales per Business

EUR in Million2021Weight2022Weight Delta
Research and Development of Innovative Medicines and Diagnostic Solutions
100.0 %
80 100.0 % 20 100.0 % -74.78%

Sales per region

EUR in Million2021Weight2022Weight Delta
France
100.0 %
80 100.0 % 20 100.0 % -74.78%

Managers

Managers TitleAgeSince
Chief Executive Officer 56 18-04-30
Founder 68 99-08-31
Director of Finance/CFO 50 21-04-21
Chief Tech/Sci/R&D Officer 47 -
Compliance Officer 43 15-12-31
Chief Operating Officer 56 19-08-31
Chief Tech/Sci/R&D Officer 64 19-09-08
Chief Tech/Sci/R&D Officer 50 22-11-30
Chief Tech/Sci/R&D Officer 61 99-12-31
Investor Relations Contact 47 14-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 67 21-03-03
Founder 68 99-08-31
Founder 52 99-09-14
Director/Board Member 82 06-10-17
Director/Board Member 68 17-06-15
Director/Board Member 56 17-06-15
Director/Board Member 61 20-07-06
Director/Board Member - 22-05-24
Director/Board Member 64 20-07-06

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 49,834,983 43,218,713 ( 86.72 %) 0 86.72 %

Shareholders

NameEquities%Valuation
IPSEN
7.997 %
3,985,239 7.997 % 14 M €
Tang Capital Management LLC
4.917 %
2,450,404 4.917 % 8 M €
Biotech Avenir SAS
3.790 %
1,888,618 3.790 % 6 M €
Universite de Lille II Foundation
1.307 %
651,250 1.307 % 2 M €
Sunny Asset Management SA
0.2408 %
120,000 0.2408 % 409 052 €
Meeschaert Asset Management SA
0.0761 %
37,911 0.0761 % 129 230 €
36,594 0.0734 % 124 741 €
Ecofi Investissements SA
0.0723 %
36,042 0.0723 % 122 859 €
OFI Invest Asset Management SA
0.0625 %
31,128 0.0625 % 106 108 €
Clay Asset Management SAS
0.0602 %
30,000 0.0602 % 102 263 €
NameEquities%Valuation
Tang Capital Management LLC
0.9621 %
479,441 0.9621 % 2 M €
Optiver Holding BV
0.1653 %
82,359 0.1653 % 285 786 €
Morgan Stanley & Co. International Plc
0.0617 %
30,763 0.0617 % 106 748 €
Millennium Management LLC
0.0568 %
28,310 0.0568 % 98 236 €
Old Mission Capital LLC
0.0249 %
12,428 0.0249 % 43 125 €
UBS Securities LLC
0.002282 %
1,137 0.002282 % 3 945 €
RhumbLine Advisers LP
0.001360 %
678 0.001360 % 2 353 €
Advisory Services Network LLC
0.000201 %
100 0.000201 % 347 €
Qube Research & Technologies Ltd. (France)
0.000197 %
98 0.000197 % 340 €

Company contact information

Genfit SA

Parc Eurasante 885, Avenue Eugène Avinée

59120, Loos

+33 3 20 16 40 00

http://www.genfit.com
address GENFIT(GNFT)